The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.
Zyn's growth trajectory in the U.S. has helped propel Philip Morris International's stock in 2024. Zyn shipments in the U.S. were up over 40% in its fiscal third quarter of 2024, compared to the same ...